Holen Sie sich die Stockscreener-App
0.751
0.09%
0.0007
Schlusskurs vom Vortag:
$0.7503
Offen:
$0.7601
24-Stunden-Volumen:
37,203
Relative Volume:
0.96
Marktkapitalisierung:
$4.81M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-21.13M
KGV:
-0.1568
EPS:
-4.79
Netto-Cashflow:
$-16.95M
1W Leistung:
+2.88%
1M Leistung:
-40.87%
6M Leistung:
-9.53%
1J Leistung:
+25.38%
1-Tages-Spanne:
$0.751
$0.85
1-Wochen-Bereich:
$0.7022
$0.8834
52-Wochen-Spanne:
$0.4748
$3.09
Matinas Biopharma Holdings Inc Stock (MTNB) Company Profile
Firmenname
Matinas Biopharma Holdings Inc
Sektor
Branche
Telefon
908-443-1860
Adresse
1545 Route 206 South, Suite 302, Bedminster, NJ
Vergleichen Sie MTNB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MTNB
Matinas Biopharma Holdings Inc
|
0.751 | 4.81M | 0 | -21.13M | -16.95M | -4.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Matinas Biopharma Holdings Inc Stock (MTNB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-05-11 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-08-26 | Fortgesetzt | Piper Sandler | Overweight |
| 2020-01-27 | Eingeleitet | Piper Sandler | Overweight |
| 2020-01-24 | Eingeleitet | SunTrust | Buy |
| 2020-01-23 | Eingeleitet | SunTrust | Buy |
| 2020-01-09 | Eingeleitet | Aegis Capital | Buy |
| 2019-06-26 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Matinas Biopharma Holdings Inc Aktie (MTNB) Neueste Nachrichten
Why Matinas Biopharma Holdings Inc. stock attracts wealthy investorsPortfolio Gains Report & Proven Capital Preservation Methods - Newser
Will Matinas BioPharma Holdings Inc. stock gain from strong economyEarnings Beat & Free Low Drawdown Momentum Trade Ideas - Newser
Will Matinas Biopharma Holdings Inc. stock sustain uptrend momentum2025 Year in Review & Fast Entry and Exit Trade Plans - Newser
How Matinas BioPharma Holdings Inc. (6LJ0) stock reacts to new regulationsTake Profit & Intraday High Probability Setup Alerts - Newser
Is Matinas Biopharma Holdings Inc. stock a top hedge fund pickOil Prices & High Return Trade Opportunity Guides - Newser
How Matinas Biopharma Holdings Inc. stock reacts to stronger dollarWeekly Stock Analysis & Free Weekly Watchlist of Top Performers - Newser
Why Matinas Biopharma Holdings Inc. stock benefits from AI revolutionQuarterly Profit Review & Risk Adjusted Buy and Sell Alerts - Newser
What insider trading reveals about Matinas BioPharma Holdings Inc. stockTake Profit & Growth Oriented Trade Recommendations - Newser
MTNB (Matinas BioPharma Holdings) Current Ratio : 3.78 (As of Sep. 2025) - GuruFocus
Matinas Biopharma Holdings Inc (MTNB) Performance and Fundamentals Dashboard tells a completely different story - Setenews
Matinas BioPharma CFO Resignation Announced - MSN
Matinas BioPharma CFO Keith Kucinski to step down in January By Investing.com - Investing.com Australia
Matinas BioPharma CFO Keith Kucinski to step down in January - Investing.com
Matinas Biopharma Holdings IncCFO Keith Kucinski resigns effective January 17, 2026SEC filing - MarketScreener
[8-K] Matinas BioPharma Holdings, Inc. Reports Material Event | MTNB SEC FilingForm 8-K - Stock Titan
Will Matinas BioPharma Holdings Inc. (6LJ0) stock split increase liquidity2025 Trade Ideas & Fast Exit and Entry Trade Guides - newser.com
Can Matinas Biopharma Holdings Inc. stock hold up in economic slowdown2025 EndofYear Setup & Safe Capital Allocation Plans - newser.com
Why institutional investors increase stakes in Matinas BioPharma Holdings Inc. (6LJ0) stockJuly 2025 Levels & Weekly Return Optimization Alerts - newser.com
What hedge fund moves indicate for Matinas Biopharma Holdings Inc. stock2025 Geopolitical Influence & Advanced Swing Trade Entry Plans - newser.com
Is Matinas BioPharma Holdings Inc. stock bottoming outWeekly Gains Report & Weekly Watchlist for Hot Stocks - newser.com
Why Matinas BioPharma Holdings Inc. stock could see breakout soonJuly 2025 Earnings & Expert Verified Movement Alerts - newser.com
Will Matinas BioPharma Holdings Inc. (6LJ0) stock see insider accumulationDividend Hike & AI Enhanced Trade Execution Alerts - newser.com
Matinas Biopharma Holdings, Inc. (MTNB) 8.04% in After-hours: Modest Price Recovery - Stocks Telegraph
Is Matinas Biopharma Holdings Inc. stock undervalued after correctionQuarterly Profit Report & High Conviction Buy Zone Alerts - newser.com
How resilient is Matinas BioPharma Holdings Inc. stock in market downturns2025 Stock Rankings & Real-Time Volume Triggers - newser.com
Is Matinas Biopharma Holdings Inc. stock prepared for digital transitionJuly 2025 WrapUp & Free Long-Term Investment Growth Plans - newser.com
How supply shortages influence Matinas BioPharma Holdings Inc. (6LJ0) stock - newser.com
Technical analysis overview for Matinas BioPharma Holdings Inc. stockQuarterly Growth Report & Daily Momentum Trading Reports - newser.com
How Matinas Biopharma Holdings Inc. stock moves on employment dataJuly 2025 Institutional & High Win Rate Trade Tips - newser.com
Will Matinas Biopharma Holdings Inc. stock test record highs in 2025Gold Moves & Fast Exit and Entry Strategy Plans - newser.com
Published on: 2025-11-19 14:39:04 - newser.com
Can Matinas Biopharma Holdings Inc. stock resist broad market declines - newser.com
Why retail traders accumulate Matinas BioPharma Holdings Inc. (6LJ0) stockJobs Report & High Win Rate Trade Alerts - newser.com
Finanzdaten der Matinas Biopharma Holdings Inc-Aktie (MTNB)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.10%
1.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):